TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — Treatment with repeat doses of rituximab is superior to daily azathioprine for preventing relapse ...

A recent report by Buckley et al analyzed a previous study to determine the differences in second and third relapse rates in patients receiving long-acting injectable risperidone versus an oral second ...

Avelumab demonstrated a 53% response rate in chemo-resistant gestational trophoblastic tumors, with no relapse after 29 months of follow-up. The study suggests avelumab as a potential alternative to ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

Medical University of South Carolina scientists report in Neuron that they have uncovered a way to restore an opioid-weakened brain pathway in a preclinical model. With funding from the National ...

John M. Kane, MD: When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. Someone who ...

Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...

Is artificial intelligence the key to preventing relapse of severe mental illness? New AI software developed by researchers at Flinders University shows promise for enabling timely support ahead of ...

Relapses can have devastating consequences for people with mental disorders such as schizophrenia, bipolar disorder, depression, or an anxiety disorder. After every relapse, it may become increasingly ...